Suppr超能文献

根治性切除的垂体腺瘤:Ki-67标记指数在单中心回顾性系列研究中的预后作用及文献综述

Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review.

作者信息

Chiloiro Sabrina, Bianchi Antonio, Doglietto Francesco, de Waure Chiara, Giampietro Antonella, Fusco Alessandra, Iacovazzo Donato, Tartaglione Linda, Di Nardo Francesco, Signorelli Francesco, Lauriola Libero, Anile Carmelo, Rindi Guido, Maira Giulio, Pontecorvi Alfredo, De Marinis Laura

机构信息

Section of Endocrinology, Department of Internal Medicine, Università Cattolica del Sacro Cuore, Policlinico Gemelli, Largo A. Gemelli, 8, 00168, Rome, Italy,

出版信息

Pituitary. 2014 Jun;17(3):267-76. doi: 10.1007/s11102-013-0500-6.

Abstract

Ki-67 Labeling Index is an immunocytochemical marker of cell proliferation. The correlation of Ki-67 expression with pituitary adenomas recurrence has been investigated and is highly debated. Aim of this study was to evaluate whether Ki-67 correlates with recurrence even in patients with an apparently completely removed pituitary adenoma. We retrospectively reviewed the database of the Hypothalamic-Pituitary Disease Unit at the Catholic University of Rome, collected between 2003 and 2011. Inclusion criteria were: patients who underwent surgery at the Department of Neurosurgery with an apparently complete removal of a pituitary adenoma; Ki-67 histological evaluation by the same operator and values of <3%. All patients underwent endocrine evaluation of the hypothalamic-pituitary function, ophthalmologic and neuro-radiological examinations, during the preoperative period and follow-up. Out of 490 patients recorded on the database of the Hypothalamic-Pituitary Disease Unit at the Catholic University of Rome, 191 cases met the inclusion criteria. Recurrence was observed in 49 cases (25.7% of the patients who had undergone radical excision). Optional cut-off value was identified at Ki-67 values of 1.50%. This was associated with worse disease-free survival time, even after correction for age at treatment, gender, positivity to p53, functional classification and Knosp grading. Ki-67 labeling index may be useful in postoperative management, even in patients who underwent radical PA removal. We suggest a Ki-67 cut-off value of 1.5% to plan an adequate clinical follow-up.

摘要

Ki-67标记指数是一种细胞增殖的免疫细胞化学标志物。Ki-67表达与垂体腺瘤复发的相关性已得到研究,但仍存在很大争议。本研究的目的是评估即使在垂体腺瘤明显完全切除的患者中,Ki-67是否与复发相关。我们回顾性分析了罗马天主教大学下丘脑-垂体疾病科2003年至2011年期间收集的数据库。纳入标准为:在神经外科接受手术且垂体腺瘤明显完全切除的患者;由同一名操作人员进行Ki-67组织学评估且值<3%。所有患者在术前和随访期间均接受了下丘脑-垂体功能的内分泌评估、眼科和神经放射学检查。在罗马天主教大学下丘脑-垂体疾病科数据库记录的490例患者中,191例符合纳入标准。49例(接受根治性切除的患者中的25.7%)观察到复发。确定Ki-67值为1.50%为可选的临界值。即使在校正治疗时的年龄、性别、p53阳性、功能分类和Knosp分级后,这也与较差的无病生存时间相关。Ki-67标记指数在术后管理中可能有用,即使在接受垂体腺瘤根治性切除的患者中也是如此。我们建议采用1.5%的Ki-67临界值来规划充分的临床随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验